Browse > Article

Inhibition of Proinflammatory Cytokine-induced Invasiveness of HT-29 Cells by Chitosan Oligosaccharide  

Nam, Kyung-Soo (Department of Pharmacology, College of Medicine, Dongguk University)
Kim, Mee-Kyung (Intractable Disease Research Center, Dongguk University)
Shon, Yun-Hee (Intractable Disease Research Center, Dongguk University)
Publication Information
Journal of Microbiology and Biotechnology / v.17, no.12, 2007 , pp. 2042-2045 More about this Journal
Abstract
The effect of chitosan oligosaccharide (COS, 1 kDa, 10 ng/ml IL-$1{\alpha}$, and 25 ng/ml TNF-${\alpha}$) in HT-29 cells. Inducible nitric oxide synthase (iNOS) expression induced by these cytokines was inhibited by COS. COS pretreatment inhibited the invasiveness of cytokines-treated HT-29 cells through Matrigel-coated membrane in a dose-dependent manner. COS also inhibited cytokines-induced matrix metalloproteinase (MMP)-2 activity. This study shows that proinflammatory cytokines induce NO production, iNOS expression, and invasiveness of human colorectal adenocarcinoma HT-29 cells. COS pretreatment inhibited cytokines-mediated NO production, iNOS expression, and invasiveness of HT-29 cells. These results provide sufficient information for the further development of COS as an antitumor metastatic agent for the treatment of colon cancer.
Keywords
Chitosan oligosaccharide; invasion; matrix metalloproteinase-2; nitric oxide; proinflammatory cytokines;
Citations & Related Records
Times Cited By KSCI : 4  (Citation Analysis)
Times Cited By Web Of Science : 10  (Related Records In Web of Science)
연도 인용수 순위
1 Brown, P. D. 1998. Matrix metalloproteinases in gastrointestinal cancer. Gut 43: 161-163   DOI   ScienceOn
2 Lagares-Garcia, J. A., R. A. Moore, B. Collier, M. Heggere, F. Diaz, and F. Qian. 2001. Nitric oxide synthase as a marker in colorectal carcinoma. Am. Surg. 67: 709-713
3 Nagase, H. and J. F. Jr. Woessner. 1999. Matrix metalloproteinases. J. Biol. Chem. 274: 21491-21494   DOI
4 Thomsen, L. L. and D. W. Miles. 1998. Role of nitric oxide in tumour progression: Lessons from human tumours. Cancer Metastasis Rev. 17: 107-118   DOI   ScienceOn
5 Yagihashi, N., H. Kasajima, S. Sugai, K. Matsumoto, Y. Ebina, T. Morita, T. Murakami, and S. Yagihashi. 2000. Increased in situ expression of nitric oxide synthase in human colorectal cancer. Virchows Arch. 436: 109-114   DOI   ScienceOn
6 Folkman, J. 1997. Angiogenesis and angiogenesis inhibition: An overview. EXS 79: 1-8
7 Vipul, G., D. Jiwan, P. Vyas, and H. S. Chhatpar. 2005. Statistical optimization of chitinase production by Pantoea dispersa to enhance degradation of crustacean chitin waste. J. Microbiol. Biotechnol. 15: 197-201   과학기술학회마을
8 Deeslie, W. D. and M. Cheryan. 1988. Functional properties of soy protein hydrolysates from a continuous ultrafiltration reactor. J. Agric. Food Chem. 36: 26-31   DOI
9 Hojilla, C. W., F. F. Mohammed, and R. Khokha. 2003. Matrix metalloproteinases and their tissue inhibitors direct cell fate during cancer development. Br. J. Cancer 89: 1817-1821   DOI   ScienceOn
10 Tamir, S. and S. R. Tannenbaum. 1996. The role of nitric oxide (NO) in the carcinogenic process. Biochim. Biophys. Acta 1288: F31-F36
11 Shin, W. S., J. C. Kil, and G. M. Park. 2006. Antiprotozoal activity of deacetylated chitosan oligosaccharide (dp 2-8) on Trichomonas vaginalis. J. Microbiol. Biotechnol. 16: 1984- 1989   과학기술학회마을
12 Jeon, C. 2005. Mercury ion removal using a packed-bed column with granular aminated chitosan. J. Microbiol. Biotechnol. 15: 497-501   과학기술학회마을
13 Morris, S. M. and T. R. Billiar. 1994. New insights into the regulation of inducible nitric oxide synthase. Am. J. Physiol. 266: E829-E839
14 Rosenblum, G., S. O. Meroueh, O. Kleifeld, S. Brown, S. P. Singson, R. Fridman, S. Mobashery, and I. Sagi. 2003. Structural basis for potent slow binding inhibition of human matrix metalloproteinase-2. J. Biol. Chem. 278: 27009-27015   DOI   ScienceOn
15 Brinckerhoff, C. E. and L. M. Matrisian. 2002. Matrix metalloproteinases: A tail of a frog that became a prince. Nat. Rev. Mol. Cell Biol. 3: 207-214   DOI   ScienceOn
16 Marletta, M. A. 1993. Nitric oxide synthase structure and mechanism. J. Biol. Chem. 268: 12231-12234
17 Izume, M. and A. Ohtakara. 1987. Preparation of Dglucosamine oligosaccharides by the enzymatic hydrolysis of chitosan. Agric. Biol. Chem. 51: 1189-1191   DOI
18 Nishimura, K., S. Nishimura, N. Nishi, I. Saiki, S. Tokura, and I. Azuma. 1984. Immunological activity of chitin and its derivatives. Vaccine 2: 93-99   DOI   ScienceOn
19 Shon, Y. H. and K. S. Nam. 2005. Induction of phase II enzymes and inhibition of cytochrome P450 isozymes by chitosanoligosaccharide. J. Microbiol. Biotechnol. 15: 183- 187   과학기술학회마을
20 Green, L. C., D. A. Wagner, J. Glogowski, P. L. Skipper, J. S. Wishnok, and S. R. Tannenbaum. 1982. Analysis of nitrate, nitrite, and [$^{15}N$]nitrate in biological fluids. Anal. Biochem. 126: 131-138   DOI   ScienceOn
21 Ambs, S., W. G. Merriam, W. P. Bennett, E. Felley-Bosco, M. O. Ogunfusika, S. M. Oser, S. Klein, P. G. Shields, T. R. Billiar, and C. C. Harris. 1998. Frequent nitric oxide synthase-2 expression in human colon adenomas: Implication for tumor angiogenesis and colon cancer progression. Cancer Res. 58: 334-341